AGS Therapeutics
PrivateLast Round
Accelerator
May 30, 2023
Company Overview
AGS Therapeutics is a biotechnology company that utilizes the natural machinery of microalgae to develop therapeutics such as mRNA, RNAi, proteins and peptides, delivered by microalgae extracellular vesicles.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Pharma Supply Chain
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
AGS Therapeutics Comparables
Compare AGS Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Ciloa | 83% | |
| Carmine Therapeutics | 82% | |
| Carus Bio | 81% | |
AGS Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | May 30, 2023 | ||||
| Series A | Dec 14, 2022 | ||||
| Grant | Jul 7, 2022 | ||||
| Pre Seed | Sep 7, 2021 |
AGS Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Government of France | Grant |
| Spartners by Servier & BioLabs | Accelerator |
| Bpifrance | Grant, Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 30, 2023
Received funding from Sparners by Servier & BioLabs.
- Dec 14, 2022
$32M round closed.
AGS Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about AGS Therapeutics's valuation, stock price, and market status.